Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-29

Clinical Trial Update: Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Trichuris suis ova (TSO) versus placebo in Crohn's disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trichuris suis ova (TSO) (Trichuris suis ova)

Snippet

Sponsor: Coronado Biosciences, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-29